Joerg Herrmann MDProfessor of Medicine, Mayo Graduate School of Medicine, Rochester, Minnesota
Dr. Joerg Herrmann received his medical training at Ruhr University, Bochum, Germany, and completed his internship in internal medicine at the University Clinic in Essen. Following a postdoctoral research fellowship, he pursued the clinician–investigator track in internal medicine-cardiology, and further training in interventional cardiology at the Mayo Clinic, Rochester, Minnesota. He then joined the staff of the Department of Cardiovascular Diseases at the Mayo Clinic, Rochester. Currently he is an Associate Professor of Medicine at the Mayo Graduate School of Medicine and serves as the director of the Cardio-Oncology Clinic and the research director of the Ischemic Heart Disease program.
Dr. Herrmann has been receiving NIH research funding, serves as a reviewer for over 30 journals, including all major cardiovascular journals. He is also a contributor to Braunwald’s Heart Disease, the associated editor of Trends in Cardiovascular Medicine, and is the editor of the textbook Clinical Cardio-Oncology.
His main research interests are cardio-oncology, cardiac biomarkers, periprocedural myocardial infarction, atherosclerosis, and vascular biology.
Dr. Joerg Herrmann participated in the 2014 and 2016 Ponatinib in CML Cardio-Oncology Advisory Board meeting organized by ARIAD Pharmaceuticals, the 2016 Carfilzomib Advisory Board meeting organized by Amgen and is a member of the Institute for Cardio-Oncology advisory panel sponsored by Bristol-Myers Squib.
Recent Contributions to PracticeUpdate:
- PCI Impact on Long-Term Survival in Ischemic Heart Disease
- AHA 2015 Scientific Sessions: High-Risk Hypertensive Patients SPRINT Toward Lower Blood Pressure Target
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: A Summary
- Clinical Outcomes in Patients With STEMI Treated With Everolimus-Eluting Stents vs Bare-Metal Stents
- Dr. Joerg Herrmann's Picks for AHA Scientific Sessions 2015
- Cardiac Diseases Following Childhood Cancer Treatment
- Combined Ischemic Perconditioning and Postconditioning in STEMI
- Effect of High-Dose Statins on DES Strut Coverage
- Outcomes of Fractional Flow Reserve by CT Angiography–Guided Diagnostics in Suspected CAD
- Fractional Flow Reserve vs Angiography for Guidance of PCI in Patients With Multivessel Coronary Artery Disease